Visual field results from a one-year multi-center randomized double-masked study comparing brimonidine tartrate to timolol maleate in the treatment of ocular hypertension and glaucoma

被引：0

作者：

Choplin, NT

机构：

[1] USN,MED CTR,DEPT OPHTHALMOL,SAN DIEGO,CA 92152

[2] USN,MED CTR,DEPT CLIN INVEST,SAN DIEGO,CA 92152

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1996年 / 37卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：2332 / 2332

页数：1

共 47 条

[31] The Safety and Efficacy of Bimatoprost/Timolol Fixed Combination: A 1-year Double-masked, Randomized Parallel Comparison to Its Individual Components in Patients With Glaucoma or Ocular Hypertension (vol 19, pg 424, 2010)
Lewis, R. A.
JOURNAL OF GLAUCOMA, 2014, 23 (09) : 663 - 663
[32] One-Year followup results of a randomized, multi-center clinical study of the NovaSure™ impedance controlled endometrial ablation system.
Galen, DI
FERTILITY AND STERILITY, 2002, 78 (03) : S112 - S112
[33] Analysis of Intraocular Pressure-Lowering Effects of Preservative-Free Tafluprost and Timolol in Patients with Open-Angle Glaucoma and Ocular Hypertension in a Phase-III, Randomized, Double-Masked Study
Grunden, John
Lupinacci, Robert
Varma, Rohit
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[34] Results of A Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP (travoprost insert) Compared to Timolol Drops for the Treatment of Patients with Open-Angle Glaucoma or Ocular Hypertension
Wilson, Christine
Sall, Kenneth N.
Bafna, Shamik
Gira, Joseph P.
McLaurin, Eugene B.
Protzko, Eugene
Sampson, Reginald
Tekwani, Navin
Tepedino, Michael
Vold, Steven
Walters, Thomas R.
Metzinger, Jamie Lynne
Mulani, Deepa
Talamo, Jonathan H.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
[35] Letter Regarding: One-Year Results of a Phase I/II Randomized, Double-Masked, Placebo-Controlled Study of Processed Amniotic Fluid Drops After PRK
Lei, Xue
CORNEA, 2024, 43 (12) : e50 - e51
[36] A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results from the Low-pressure Glaucoma Treatment Study (vol 151, pg 671, 2011)
Krupin, T.
Liebmann, J. M.
Greenfield, D. S.
Ritch, R.
Gardiner, S.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (06)
[37] Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study
Uusitalo, Hannu
Pillunat, Lutz E.
Ropo, Auli
ACTA OPHTHALMOLOGICA, 2010, 88 (01) : 12 - 19
[38] A single-center, double-masked, randomized, vehicle-controlled, parallel-group study evaluating the efficacy and safety of brimonidine tartrate ophthalmic solution 0.025% used four times daily in a population of adult and geriatric subjects with ocular redness
Scassellati-Sforzolini, Baldo
Ngumah, Quintus
Gomes, Paul J.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[39] ONE-YEAR OUTCOMES FROM A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (RCT) OF REFEEDING IN ANOREXIA NERVOSA: THE STUDY OF REFEEDING TO OPTIMIZE INPATIENT GAINS (STRONG)
Golden, Neville H.
Cheng, Jing
Kapphahn, Cynthia
Buckelew, Sara M.
Machen, Vanessa I.
Kreiter, Anna A.
Accurso, Erin C.
Adams, Sally H.
Le Grange, Daniel
Moscicki, Anna-Barbara
Sy, Allyson
Wilson, Leslie S.
Garber, Andrea K.
JOURNAL OF ADOLESCENT HEALTH, 2021, 68 (02) : S8 - S8
[40] One-year results from the REDUCER-I multi-center real-world clinical trial of the treatment of refractory angina with the coronary sinus Reducer
Verheye, S.
Van De Hoef, T.
De Silva, R.
Van Kuijk, J. P.
Byrne, J.
Montorfano, M.
Buschmann, E.
Dupont, M.
Banai, S.
EUROPEAN HEART JOURNAL, 2024, 45

← 1 2 3 4 5 →